| PERIOD ENDING | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | 31-Oct-08 | | Total Revenue | 357,114 | 379,110 | 679,390 | 364,130 | | Cost of Revenue | 186,403 | 190,878 | 382,088 | 189,203 | | | Gross Profit | 170,711 | 188,232 | 297,302 | 174,927 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 221,246 | 209,508 | 284,382 | 219,113 | | Non Recurring | 56,874 |
-
| 13,221 |
-
| | Others | 14,449 | 14,454 | 14,943 | 15,101 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (121,858) | (35,730) | (15,244) | (59,287) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (121,858) | (35,730) | (15,244) | (59,287) | | Interest Expense | 1,766 | 1,929 | 3,233 | 3,471 | | Income Before Tax | (123,624) | (37,659) | (18,477) | (62,758) | | Income Tax Expense | (26,239) | (14,465) | 5,098 | (17,409) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (97,385) | (23,194) | (23,575) | (45,349) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (97,385) | (23,194) | (23,575) | (45,349) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($97,385) | ($23,194) | ($23,575) | ($45,349) |
|
1.23% Nasdaq 0.00%
Income Statement
